Skip to main content
BMC Gastroenterology logoLink to BMC Gastroenterology
. 2022 Jun 17;22:298. doi: 10.1186/s12876-022-02339-1

Correction: Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia

Ulrike Ries Feddersen 1,, Sebastian Kjærgaard Hendel 1, Mark Alexander Berner-Hansen 1, Thomas Andrew Jepps 2, Mark Berner-Hansen 1, Niels Bindslev 2
PMCID: PMC9206375  PMID: 35715746

Correction to: BMC Gastroenterology (2022) 22:234 10.1186/s12876-022-02311-z

After publication of this article [1], the authors reported that the last sentence of the Conclusions section “The observed aberrant gene expressions,” should have read: “The observed aberrant gene expressions, as an individual predisposition for early tumorigenesis, is still an open question.”

The original article [1] has been updated.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Feddersen UR, Hendel SK, Berner-Hansen MA, et al. Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia. BMC Gastroenterol. 2022;22:234. doi: 10.1186/s12876-022-02311-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Gastroenterology are provided here courtesy of BMC

RESOURCES